BMC Cardiovascular Disorders · Aug 21, 2026

Associations of C-reactive protein-triglyceride-glucose index and cholesterol-high-density lipoprotein-glucose index with heart disease risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a cohort study from CHARLS

By Dong Q, Jiang M, Zheng X et al.

BACKGROUND: Although the C-reactive protein-triglyceride-glucose index (CTI) and cholesterol-high-density lipoprotein-glucose index (CHG) have both been implicated in adverse cardiovascular outcomes, their comparative predictive performance for incident heart disease among individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3 remains to be elucidated. METHODS: We analyzed 6,740 participants with CKM syndrome stages 0-3 from the China Health and Retirement Longitudinal Study (CHARLS). Stratified Cox regression models were constructed to examine the associations of CTI and CHG with incident heart disease. Restricted cubic spline (RCS), Kaplan-Meier, time-dependent receiver operating characteristic (ROC), mediation, subgroup, and sensitivity analyses were performed. RESULTS: During up to 9 years follow-up, 1,229 participants (18.2%) developed heart disease. In fully adjusted models, compared with the lowest quartile, participants in the highest quartile had a higher risk of heart disease for both CTI (HR = 1.34, 95% CI: 1.14-1.60) and CHG (HR = 1.19, 95% CI: 1.02-1.40). RCS analyses supported approximately linear associations between both indices and heart disease risk. Both indices demonstrated limited discriminatory ability (AUC range 0.516-0.554), with CTI showing slightly higher AUC values than CHG at 2 and 4 years. Systolic Blood Pressure mediated approximately 20% of the associations, with similar findings for Diastolic Blood Pressure and Mean Arterial Pressure. Subgroup and sensitivity analyses consistently supported the robustness of these findings. CONCLUSIONS: CTI and CHG are independently associated with incident heart disease in individuals with CKM syndrome stages 0-3 but exhibit weak discriminatory performance as standalone markers. CTI demonstrated a marginal advantage in discrimination over CHG, especially during the first four years of follow-up, indicating that inflammatory biomarkers might offer additional risk information beyond metabolic markers alone.

doi.org/10.1186/s12872-026-06485-2Open accessPubMed 43040255Biomarkers

AgingResearch.News